Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone-iodine ear wash and oral co-trimoxazole for chronic suppurative otitis media in Nigerian children
PACTR202412520985506Phase 3Not yet recruiting
- Sponsor
- Semen Stephen Yikawe
- Start
- Jan 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of trimethoprim + sulfamethoxazole, povidone-iodine and ciprofloxacin in chronic suppurative otitis media (CSOM) (4 arms), sponsored by Semen Stephen Yikawe. Primary endpoint: Clinical failure after treatment. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
trimethoprim + sulfamethoxazolepovidone-iodineciprofloxacin
03
Conditions
chronic suppurative otitis media (CSOM)
Beyond the preview
Go deeper on PACTR202412520985506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412520985506.